Fujifilm Healthcare Americas Corp. has launched Tracmotion, a new endoscopic submucosal dissection (ESD) device. ESD is an alternative to piecemeal resection or invasive surgery, and is utilized for en bloc resection of large, potentially cancerous polyps or tumors in the gastrointestinal tract.

Inserted through the instrument channel of an endoscope, Tracmotion’s 360° rotatable jaws enable easy grasping and re-grasping of large lesions, which enhances a clinicians visualization, streamlines the lesion extraction process, and offers the potential to reduce ESD procedure times.

“While ESD is frequently performed globally, these procedures are conducted at a significantly lower rate in U.S. hospitals and clinics, due to procedural degree of technical difficulty, device availability, training opportunities, lack of structured payer reimbursement and longer procedure times,” says Taisuke Fujita, vice president, endoscopy, Fujifilm Healthcare Americas Corp.

“Fujifilm has a longstanding commitment to innovation, and we’re proud to bring Tracmotion to market to support U.S. gastroenterologists while performing ESD procedures, which can be curative for early-stage esophageal, gastric, and colon cancer,” Fujita adds.

With Tracmotion, an endoscopist uses single-hand movements to control the distal end of the product, independent of the endoscope’s movement. Tracmotion can hold tissue during ESD without complicated locking mechanisms, demonstrating additional efficiencies when used during this advanced procedure. 

“I have had early clinical experience with Tracmotion, and it has shown a potential to positively impact my practice by decreasing the amount of time for my ESD procedures as well as helping to reduce the amount of lifting agent and the number of devices used during the procedure,” says Alexander Schlachterman, MD, PhD, associate professor, advanced endoscopy, director, Third Space Endoscopy, Thomas Jefferson University Hospital in Philadelphia.

Tracmotion was designed to be used with Fujifilm’s newly-launched EI-740D/S, the first dual-channel endoscope cleared by the U.S. FDA for use in both upper and lower gastrointestinal applications. The endoscope features two instrument channels so clinicians can perform procedures that require a range of instruments and devices, including Fujifilm’s ClutchCutter and FlushKnife